A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

AI-generated ?

Introduced

In Committee

Passed One Chamber

Passed Both Chambers

Signed into Law

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

AI summary is being generated. Check back soon!

How Congress Voted

No lobbying filings reference this bill.

Take Action on This Bill

Write a Letter

Send a letter to your representatives via ResistBot

S 5059 · 119th Congress · July 21, 2026

Take Action on This Bill

Write a Letter

Send a letter to your representatives via ResistBot